Idiopathic inflammatory muscle diseases. Dr. Paul Etau Ekwom MBChB, MMED Kenyatta National Hospital, Nairobi-Kenya

Similar documents
Inflammatory Myopathies 4 th year MBBS. Marwan Adwan MBChB, MSc, MRCPI, MRCP(rheum) Consultant Rheumatologist

Autoantibodies in the Idiopathic Inflammatory Myopathies

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

IDIOPATHIC INFLAMMATORY MYOPATHIES AND RELATED DISORDERS. Franclo Henning Division of Neurology Tygerberg Hospital

POLYMYOSITIS (PM) DERMATOMYOSITIS (DM) Body myositis Eosinophilic myositis Giant cell myositis Focal / localised myositis Myopathies caused by

L. Nandini Moorthy, MD MS 2012

The many faces of myositis. Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands

Rheumatology E-learning. University of Szeged Department of Rheumatology and Immunology

Arthritis Superspeciality Center, Hubli, Karnataka and 2 Department of Rheumatology, SDM Medical College, Dharwad, Karnataka, India.

Myositis and Your Lungs

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

4/16/2018. Demystifying weakness: how to approach refractory myositis. Objectives. Disclosures. Off-label uses for medications will be discussed

HUNGARIAN MYOSITIS COHORT

Dermatomyositis Advice from Experts: Improving Your Medical Dermatology Diagnostic and Management Skills Jeffrey P. Callen, MD Professor of Medicine

Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital

Discovery, Understanding, and Progress in Myositis

Myositis 101. Steven R. Ytterberg, M.D. Division of Rheumatology Mayo Clinic, Rochester, MN

This month, we are very pleased to introduce some new tests for Scleroderma as well as some test changes to our existing scleroderma tests/panels.

What your autoantibodies tell us about your disease. Mark Gourley, MD

What are Autoantibodies and how do they work in Myositis?

Case Report Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies

MYOSITIS. A physician s guide to the

PAEDIATRIC VASCULITIS

DR.JANANI RAVI DR.GNANABALAN S UNIT DR.MEHTA CHILDREN HOSPITAL

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

JUVENILE DERMATOMYOSITIS

Idiopathic inflammatory myopathies excluding inclusion body myositis

Is it Autoimmune or NOT! Presented to AONP! October 2015!

Idiopathic inflammatory myopathies

Muscle Pathology Surgical Pathology Unknown Conference. November, 2008 Philip Boyer, M.D., Ph.D.

Autoantibodies in Idiopathic Inflammatory Myopathies. Vidya Limaye Rheumatology Department Royal Adelaide Hospital

Autoantibodies andprognosis. Jiří Vencovský Institute of Rheumatology, Prague, Czech Republic

Evolving Uses of IVIG in myositis

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT

Clinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18

Objectives. Non-Traumatic Muscle Pathologies. Abnormal Muscle Signal Intensity. Inflammatory Myositis. Polymyostis / Dermatomyositis.

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

Complex repetitive discharge on electromyography as a risk factor for malignancy in idiopathic inflammatory myopathy

Physiotherapy in Juvenile Dermatomyositis

Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies

Acute Emergencies in Rheumatology

Clinical Laboratory. [None

SCLERODERMA SPECTRUM DISEASE

STUDIES ON INTERLEUKIN-1 IN IDIOPATHIC INFLAMMATORY MYOPATHIES

Test Name Results Units Bio. Ref. Interval

9/13/2015. Nothing to disclose

Disorders of Muscle. Disorders of Muscle. Muscle Groups Involved in Myopathy. Needle Examination of EMG. History. Muscle Biopsy

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositisudermatomyositis: correlation with interstitial lung disease

CHECK LIST FORM-MONTH 27 (Please note Month 27 is from enrolment not randomisation)

Significance of antibody testing in idiopathic inflammatory myopathies

Case 1: History of J.H. Outside Evaluation. Outside Labs. Question #1

Serologic Markers CONVENTIONAL ANTIBODIES ANTIBODIES UNCONVENTIONAL. AIH Type I

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT

Myasthenia Gravis. Mike Gilchrist 10/30/06

Myosites du sujet âgé

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS

Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis

The idiopathic inflammatory myopathies

Clinical Commissioning Policy Proposition:

Immune tolerance, autoimmune diseases

SCLERODERMA OVERLAP SYNDROME: A CASE REPORT Diwakar K. Singh 1, Nataraju H. V 2

Clinical features of seven Japanese patients with anti-pl- antibody frequent positivity for anti-cyclic citrullinated peptide antibody

Myositis and Autoimmune ILD

Complete Resolution of Dermatomyositis with Refractory Cutaneous Vasculitis by Intravenous Cyclophosphamide Pulse Therapy

PedsCases Podcast Scripts

myopathy and interstitial lung dise

Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease

Development of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.

Myasthenia gravis. David Hilton-Jones Oxford Neuromuscular Centre

A CRP B FBC C LFT D blood culture E uric acid

ACR 2017 SAN DIEGO HIGHLIGHTS - INFLAMMATORY MYOPATHIES. Nikolaos Marketos Rheumatologist Volos,

DocSpot what patients want to know

The Johns Hopkins Hospital

Living with Lupus: An Insider s Perspective

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP

Idiopathic inflammatory myopathies are a group of autoimmune

Annual Rheumatology & Therapeutics Review for Organizations & Societies

CASE REPORT. Introduction. Case Report

Overview of Diagnostic Autoantibodies in Inflammatory Myopathy

CHECK LIST FORM-SCREENING

Tools to Aid in the Accurate Diagnosis of. Connective Tissue Disease

*Pari Basharat ABSTRACT OVERVIEW OF IDIOPATHIC INFLAMMATORY MYOPATHIES

Everyday Vasculitis (or what questions do we get asked most!) Lucy Smyth Renal Consultant

Diseases of Muscle and Neuromuscular Junction

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation

Rheumatology Primer: What Labs and When

MYOSITIS 101. Your guide to understanding myositis

Vasculitides in Surgical Neuropathology Practice

Skin Manifestations of Dermatomyositis. Victoria P. Werth, M.D. University of Pennsylvania. Chief, Dermatology Philadelphia VAMC

Department of Paediatrics Clinical Guideline

Disclosures. Outline. Classification of scleroderma. Forms of SSc Like Syndromes. Systemic Sclerosis (Scleroderma)

A RARE NEUROLOGICAL PRESENTATION OF SLE. Dr Yoganand M N Dr Prithvi P Nayak

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi

Test Name Results Units Bio. Ref. Interval

APPROACH TO PATIENTS WITH POLYARTHRALGIA

Understanding Myositis Medications

Rituximab Therapy for Myopathy Associated With Anti Signal Recognition Particle Antibodies: A Case Series

Transcription:

Idiopathic inflammatory muscle diseases. Dr. Paul Etau Ekwom MBChB, MMED Kenyatta National Hospital, Nairobi-Kenya

I.W, 28 YRS, FEMALE SHOP STEWARD Referred to KNH on 16/06/09 from Thika Nursing Home Weakness for 3/12 Difficulty swallowing for 3/52

Progressive weakness :neck muscles then limb girdle. Weakness had no diurnal pattern. No reported muscle pain. Progressive dysphagia, no odynophagia Associated fatigue. No diplopia, ptosis or sphincter involvement

h/o weight loss H/o arthralgia but no other no other historical features to suggest connective tissue disease No history of pregnancy losses or any clotting. No symptoms of thyroidal illness No h/o drug use reported, no alcohol use. No known exposure to any toxins or heavy metals. No vaginal bleeding, breast lump, altered bowel habits, cough reported

Seen initially by ENT team, came with barium meal that showed? Prox. Esophageal mass..panendoscopy and biopsy results were negative.

Examination Young female, ill looking with a nasogastric tube in place. Normal hair distribution and character, no oral ulcers, no malar rash, no cutaneous features of dermatomyositis or scleroderma noted. Limb girdle and neck weakness with decreased muscle power; power grade 2. normal deep tendon reflexes and tone. Distal muscle groups power grade 4-5

Laboratory tests TBC: Leucocytosis; WBC 15.1, Hb 14.7, plt 602 ESR 45 mm/hr. CPK: normal levels LDH: elevated 674 U/L, AST 60 u/l, ALT 45 u/l RBS: 4.6 mmol/l htsh: 0.48 uiu/ml (0.25-5) Urinalysis : normal

Creatinine 68 umol/l; egfr : 89.5 mls/min ANA: positive HIV 1 and 2 ELISA: Negative HBsAg: Negative. HCV serology: negative. Blood cultures: negative Anti-DSDNA: positive. RF: positive Tensilon test : negative

Plain radiograph chest: normal. ECG/echo: normal EMG: proximal upper and lower limb muscles showed myopathic potentials. Nerve conduction studies were normal. Histology: myositis; bundles of skeletal muscles with inflammation and degenerative changes. Heavy infiltration of lymphocytes with myolysis.

By Bohan Peter criteria (1975) fulfils diagnosis of polymyositis. Bohan and peter criteria Symmetric proximal muscle weakness Elevation of muscle enzymes: CK,LDH,AST, ALT Abnormal EMG with myopathic potentials, fibrillations Muscle biopsy with features of infiltration with lymphocytes, necrosis and regeneration. Typical skin rash for dermatomyositis ; for diagnosis of dermatomyositis. In view of young female, arthralgia and positive ANA, dsdna,? SLE Overlap syndrome

Differential diagnosis of I.I.M Viral myositis: Coxsackie virus, echo, influenza viruses, HIV, Hepatitis virus Bacterial and parasitic infections: Pyomyositis, Trichinella spiralis, Trypanosomiasis. Alcoholic myopathy Diabetes myopathy DRUGS :Statins, fibrates,zidovudine, HCQ, cimetidine,colchicine, glucocorticoids. Muscular dystrophies Thyroidal illness Vasculitis Myasthenia gravis. Neuropathies Granulomatous myositis: sarcoidosis

Treatment Prednisolone 60mg/day and taper. Methotrexate started at 7.5 mg/week Folate Omeprazole Calcium/vitamin D NGT feeding..currently removed, able to swallow. Physiotherapy: exercises.

I.I.M Rare disorders Combined incidence of 2-7 per million population. Three main subgroups, dermatomyositis (DM), polymyositis (PM) and inclusion body myositis (IBM) Polymyositis and dermatomyositis are commoner in Females than males; 3:1. Inclusion body myositis is commoner in men. Peak age 50-60 (Though PM,DM may start at any age) They each may present in isolation or with a connective tissue disorder ;SLE, RA, Sjögren's syndrome, polyarteritis nodosa (PAN), scleroderma and mixed connective tissue disease.

Causes PM/DM are autoimmune diseases with association with with genetic HLA class II alleles. IBM is thought to be a degenerative disorder due to presence of tau proteins and amyloid. Association with viral infections. Association with malignancy in DM; haematological, lung, ovary, breast, colon. In polymyositis, association with malignancy is uncertain.

Clinical features Muscle weakness and fatigue. Cutaneous features : Gottron s changes, heliotrope rash, periungal capillary changes, mechanic hands, ulcers, livedo reticularis, subcutaneous calcinosis. Raynauds phenomenon Dyspnoea. Arthralgia and non-erosive arthritis. Dysphagia, reflux. Cardiovascular: congestive heart failure, conduction abnormalities, coronary artery disease. Amyopathic dermatomyositis.

Diagnosis Muscle enzymes: CPK, LDH, AST,ALT, ALDOLASE. Myoglobin EMG Muscle biopsy. Imaging: MRI-T1,2 and STIR sequences. Autoantibodies: ANA- in 60-70%. Anti aminoacyl t RNA synthetase ( Anti Jo-1) Anti Mi-2, anti-signal recognition particle (anti-srp). Anti 155-140 in dermatomyositis associated with cancer Anti CADM 40 in amyopathic dermatomyositis. Anti-SUMO 1 antibodies in DM with ILD

Other tests ECG, ECHO Pulmonary function tests CT scan chest. Tests to r/o differentials: viral serologies, HIV tests, Blood sugar, thyroid profile

Screening for malignancies History and examination. DRE, breast and pelvic examination. Xray chest Mammogram. FOBT PNS examination Abdomen and pelvic imaging.

Treatment options Glucocorticoids Immunosuppressive therapy: Methotrexate Azathioprine MTX and AZA Cyclosporine Cyclophosphamide Mycophenolate mofetil Ivig ATG

Progress Muscle strength CPK ESR, CRP

asante any comments?